Publikace
- Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy2016 | Lékařská fakulta v Plzni
- Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics2016 | Lékařská fakulta v Plzni
- The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study2015 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Predictive Role of CEA and CYFRA 21-1 in Patients with Advanced-stage NSCLC Treated with Erlotinib2014 | Lékařská fakulta v Plzni
- Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib2014 | Lékařská fakulta v Plzni
- Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice2013 | Lékařská fakulta v Plzni
- Chylózní ascites jako závažná komplikace neuroendokrinního tumoru ilea - kazuistika2013 | Lékařská fakulta v Plzni
- Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer2012 | Lékařská fakulta v Plzni
Loading network view...